Literature DB >> 6279359

Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines.

R V Pollock, L E Carmichael.   

Abstract

Inactivated canine parvovirus (CPV) and inactivated feline panleukopenia virus (FPV) vaccines were evaluated in dogs. Maximal serologic response occurred within 1-2 weeks after vaccination. Antibody titers then declined rapidly to low levels that persisted at least 20 weeks. Immunity to CPV, defined as complete resistance to infection, was correlated with serum antibody titer and did not persist longer than 6 weeks after vaccination with inactivated virus. However, protection against generalized infection was demonstrated 20 weeks after vaccination. In unvaccinated dogs, viremia and generalized infection occurred after oronasal challenge with virulent CPV. In contrast, viral replication was restricted to the intestinal tract and gut-associated lymphoid tissue of vaccinated dogs. Canine parvovirus was inactivated by formalin, beta-propiolactone (BPL), and binary ethylenimine (BEI) in serum-free media; inactivation kinetics were determined. Formalin resulted in a greater loss of viral HA than either BEI of BPL, and antigenicity was correspondingly reduced.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279359

Source DB:  PubMed          Journal:  Cornell Vet        ISSN: 0010-8901


  15 in total

1.  Canine parvovirus (CPV) vaccination: comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine.

Authors:  A Pratelli; A Cavalli; V Martella; M Tempesta; N Decaro; L E Carmichael; C Buonavoglia
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Studies on canine parvovirus infection: preparation of challenge virus.

Authors:  L Macartney; I A McCandlish; H Thompson; H J Cornwell
Journal:  Res Vet Sci       Date:  1988-09       Impact factor: 2.534

3.  Latex agglutination test for detecting feline panleukopenia virus, canine parvovirus, and parvoviruses of fur animals.

Authors:  P M Veijalainen; E Neuvonen; A Niskanen; T Juokslahti
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

4.  WSAVA Guidelines for the vaccination of dogs and cats.

Authors:  M J Day; M C Horzinek; R D Schultz; R A Squires
Journal:  J Small Anim Pract       Date:  2016-01       Impact factor: 1.522

5.  Canine parvovirus infection, canine distemper and infectious canine hepatitis: inclination to vaccinate and antibody response in the Swedish dog population.

Authors:  P Olson; A Hedhammar; B Klingeborn
Journal:  Acta Vet Scand       Date:  1996       Impact factor: 1.695

6.  Sequence analysis of a canine parvovirus isolated from a red panda (Ailurus fulgens) in China.

Authors:  Qin Qin; I Kati Loeffler; Ming Li; Kegong Tian; Fuwen Wei
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

Review 7.  Canine parvovirus.

Authors:  R V Pollock; M J Coyne
Journal:  Vet Clin North Am Small Anim Pract       Date:  1993-05       Impact factor: 2.093

8.  Recombinant vaccine for canine parvovirus in dogs.

Authors:  J A López de Turiso; E Cortés; C Martínez; R Ruiz de Ybáñez; I Simarro; C Vela; I Casal
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

9.  B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface.

Authors:  J P Langeveld; J I Casal; C Vela; K Dalsgaard; S H Smale; W C Puijk; R H Meloen
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  The duration of immunity to an inactivated adjuvanted canine parvovirus vaccine. A 52 and 64 week postvaccination challenge study.

Authors:  R C Povey; P S Carman; E Ewert
Journal:  Can Vet J       Date:  1983-08       Impact factor: 1.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.